The Partnership For Safe Medicines Congressional Briefings, January 31, 2019
On Thursday, January 31, 2019, victims of counterfeit medicines and their families, local law enforcement, former DEA agents, and other experts in the fight against counterfeit medicines met for a discussion about the widespread impact fake drugs are having on communities and on the enormous burden the problem places on regulators who are responsible for our drug safety.
Since last year's briefing in April 2018, the number of states reporting fake counterfeit medicine laced with fentanyl or fentanyl analogues has risen from 43 to 46. 29 of those states have linked deaths to the drugs.
- The Partnership for Safe Medicines Congressional Briefing (April 10, 2018)
- The Partnership For Safe Medicines Congressional Briefing (March 16 and 17, 2017)
- "Current Threats to American Patients from Counterfeiters," PSM Counterfeit Drug Congressional Briefing (March 7 and 8, 2016)
- "Moving Beyond the Avastin Incident," PSM Counterfeit Drug Congressional Briefing held on March 15 (March 09, 2012)
- Dr. Bryan Liang Speaking at a Congressional Briefing (March 01, 2012)
- Congressional Briefing: The Human Impact of Counterfeit Drugs (September 13, 2011)
- Fake Online Pharmacies US Congressional Briefing (June 23, 2011)
- Prescription Drug Safety Hill Briefing (March 30, 2011)